Ledger.Open graph →
SEC Form D · filed February 6, 2014

Regulus Therapeutics Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Mark G. Foletta · San Diego, CADirectorJohn H. Maraganore · San Diego, CADirectorWilliam H. Rastetter · San Diego, CADirectorDavid Baltimore · San Diego, CADirectorBruce L. Carter · San Diego, CADirectorB. L. Parshall · San Diego, CADirectorNeil L. Gibson · San Diego, CAExecStelios H. Papadopoulos · San Diego, CADirectorKleanthis Xanthopoulos · San Diego, CAExec · DirectorDouglas E. Williams · Berkeley, CADirectorJeremy Burr · El Dorado Hills, CADirectorSuken Shah · Palo Alto, CADirectorDave E. Trucano · NEW YORK, NYDirectorJames E. Keenan · NEW YORK, NYDirectorJennifer W. Foster · STAMFORD, CTExecJames W. Henderson · STAMFORD, CTDirectorRichard L. Chilton · STAMFORD, CTExec · DirectorMark G. Foletta · San Diego, CADirectorDouglas E. Williams · San Diego, CADirectorWilliam H. Rastetter · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗